Magellan Health Inc (MGLN) Stock
MGLN is no longer traded. Magellan Health was acquired by Centene (CNC) on January 4, 2022.
Each MGLN share was exchanged for $95.00 in cash. Prices on this page are historical; the last trade was December 31, 2021 at $94.99.
See Centene (CNC) stock →Magellan Health stock price history
MGLN final trading statistics
- Final close
- $94.99
- Final trading day
- Dec 31, 2021
- Market cap at delisting
- $2.50B
- Shares outstanding
- 26.33M
- Final 52-week range
- $82.94 – $99.36
- Avg. volume (final 3 mo.)
- 169,184
- All-time high (split-adj.)
- $10395.00 · Aug 1997
- All-time low (split-adj.)
- $8.32 · May 2003
- Return since IPO
- -96.0%
- Beta
- 1.04
- Book value / share
- $73.44
- Price / book
- 1.29
Magellan Health annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2020 | $4.58B | $382.3M | $2.09 |
| FY2019 | $7.16B | $55.9M | $2.28 |
| FY2018 | $7.31B | $24.2M | $0.91 |
| FY2017 | $5.84B | $110.2M | $4.46 |
| FY2016 | $4.84B | $77.9M | $3.26 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Magellan Health Inc
Magellan Health, Inc., together with its subsidiaries, provides healthcare management services in the United States. The company operates in Healthcare and Pharmacy Management segments. The Healthcare segment offers carve-out management services for behavioral health; employee assistance plans; and other areas of specialty healthcare, including diagnostic imaging, musculoskeletal management, cardiac, and physical medicine. It also contracts with state Medicaid agencies, and the centers for Medicare and Medicaid services to manage care for beneficiaries under Medicaid and Medicare programs, such as healthcare and long-term support services through its network of medical and behavioral health professionals, clinics, hospitals, nursing facilities, home care agencies, and ancillary service providers. The Pharmacy Management segment comprises products and solutions that provide clinical and financial management of pharmaceuticals paid under medical and pharmacy benefit programs. Further, it offers pharmacy benefit management services, such as pharmaceutical dispensing services; pharmacy benefit administration for state Medicaid and other government sponsored programs; clinical and formulary management programs; medical pharmacy management programs; and programs for the integrated management of specialty drugs that treat complex conditions. In addition, the company provides services to health plans and managed care organizations, employers, labor unions, third party administrators, state governments, military and governmental agencies, exchanges, brokers, and consultants. Magellan Health, Inc. was incorporated in 1969 and is headquartered in Phoenix, Arizona. As of January 4, 2022, Magellan Health, Inc. operates as a subsidiary of Centene Corporation.
Magellan Health stock FAQ
What happened to Magellan Health stock?
Magellan Health was acquired by Centene (CNC) on January 4, 2022. Shareholders received $95.00 in cash for each share. MGLN stock stopped trading on the Nasdaq, with a final close of $94.99 on December 31, 2021.
What did Magellan Health shareholders receive?
Each MGLN share was converted into $95.00 in cash. The deal was valued at about $2.2 billion.
Is MGLN stock still trading?
No. MGLN was delisted from the Nasdaq on January 4, 2022 and no longer trades on a U.S. exchange.
What was the last price of MGLN stock?
MGLN closed at $94.99 on its final trading day, December 31, 2021, for a market value of about $2.50B.
What were Magellan Health's revenue and earnings in its last full fiscal year?
Magellan Health reported revenue of $4.58B and net income of $382.3M in fiscal 2020, its last full year as a public company.
When did Magellan Health go public?
Magellan Health Inc stock began trading on February 25, 2004.